drugset / Trial / NCT00734435

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

NCT00734435

Phase 2 Terminated 26 enrolled Orexigen Therapeutics, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if zonisamide SR will prevent weight gain in schizophrenic subjects who take olanzapine (Zyprexa)

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zonisamide Other / unclassified 90 mg
Comparator Olanzapine Small molecule 10 mg
Comparator Olanzapine Small molecule 20 mg